Doceree Funding: How Much Did They Raise & Key Investors

How Much Did Doceree Raise?
Funding & Key Investors

Doceree, a prominent player in the healthcare professional (HCP) programmatic marketing sector, has successfully secured a significant capital injection, bringing its total funding to $59.6M. This latest strategic investment of $13.6M underscores the company's robust growth trajectory and its pivotal role in bridging the communication gap between life sciences brands and medical practitioners. By leveraging proprietary data tools, Doceree continues to solidify its market position as a leader in digital health marketing infrastructure.

The firm's financial journey, characterized by a series of strategic financing rounds, reflects a clear progression from early-stage development to a mature enterprise-level operation. This recent infusion of capital is expected to accelerate the deployment of its programmatic solutions across global markets, ensuring that life sciences companies can engage HCPs with unprecedented precision and transparency.

What is Doceree?

Doceree

Business Services

Software Testing

Advertising Networks

Doceree operates as a sophisticated global platform designed to revolutionize how life sciences organizations interact with healthcare professionals. By utilizing an extensive network of digital endemic and point-of-care platforms, the company facilitates programmatic messaging that is both personalized and measurable. Its core value proposition lies in its ability to provide transparent marketing campaign metrics at scale, effectively solving the fragmentation issues often found in traditional medical marketing. As the industry shifts toward data-driven engagement, Doceree's proprietary technology serves as a critical conduit for high-impact, compliant communication in the healthcare ecosystem.

How much funding has Doceree raised?

Doceree has raised a total of $59.6M across 4 funding rounds:

2021

Debt

$26K

2022

Series A

$11M

2023

Series B

$35M

2024

Series B

$13.6M

Debt (2021): $26K with participation from PPP

Series A (2022): $11M led by Eight Roads, F-Prime Capital Partners, and Alkemi International

Series B (2023): $35M supported by F-Prime Capital Partners and Eight Roads

Series B (2024): $13.6M, investors not publicly disclosed

Key Investors in Doceree

F-Prime Capital Partners

Founded in 2002, F-Prime Capital provides a team of investors, engineers, doctors, and scientists dedicated to investing in health care and technology for other companies.

Eight Roads

Eight Roads is a venture capital investment company specializing in real estate, venture, and growth businesses with a global reach.

Alkemi International

Alkemi International is a specialized marketing agency focused on conversion rate optimization and verifiable bottom-line results for its partners.

What's next for Doceree?

With the successful closure of this latest funding round, Doceree is well-positioned to scale its operations and enhance its technological capabilities. The company's strategic roadmap likely involves expanding its global footprint and deepening its integration with point-of-care digital platforms. By focusing on advanced analytics and programmatic efficiency, Doceree aims to set new benchmarks for HCP engagement. Investors are closely watching how this capital will be deployed to maintain the company's competitive edge in the rapidly evolving health-tech landscape, particularly as it seeks to further optimize conversion rates and campaign performance for its life sciences clientele.

See full Doceree company page

See More Financial Insights